Christie et al. targeted both VEGF and VEGFR2 with their cRGD micelle-siRNA particle, which was stabilized with 2-iminothiolane; compared to untreated tumors, these particles reduced tumor growth by more than 80% [27]. This evidence concerns the gene VEGFA and neoplasm.